Copyright
©The Author(s) 2023.
World J Stem Cells. May 26, 2023; 15(5): 476-489
Published online May 26, 2023. doi: 10.4252/wjsc.v15.i5.476
Published online May 26, 2023. doi: 10.4252/wjsc.v15.i5.476
Figure 4 Exosomes from circular RNA astrotactin 1-modified adipose-derived mesenchymal stem cells have greater therapeutic effect in promoting wound healing in a diabetic mouse model.
A: Representative images of full-thickness skin defects after treatment with adipose-derived mesenchymal stem cell (ADSC) exosomes or circular RNA astrotactin 1-modified ADSC exosomes for 0, 1, and 2 wk after wounding; B and C: Microvascular formation evaluated by immunofluorescence staining with cluster of differentiation 31. bP < 0.001 vs control. dP < 0.001 vs exosomes; D and E: We assayed apoptosis level via terminal deoxynucleotidyl transferase dUTP nick end labeling staining. bP < 0.001 vs control. dP < 0.001 vs exosomes; F: Hematoxylin and eosin staining shows wound changes; G-I: Quantitative polymerase chain reaction and western blot analysis showing mi-138-5p (G), SIRT1 (H), and forkhead box O1 (I) expression. bP < 0.001 vs control. dP < 0.001 vs exosomes.
- Citation: Wang Z, Feng C, Liu H, Meng T, Huang WQ, Song KX, Wang YB. Exosomes from circ-Astn1-modified adipose-derived mesenchymal stem cells enhance wound healing through miR-138-5p/SIRT1/FOXO1 axis regulation. World J Stem Cells 2023; 15(5): 476-489
- URL: https://www.wjgnet.com/1948-0210/full/v15/i5/476.htm
- DOI: https://dx.doi.org/10.4252/wjsc.v15.i5.476